These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38382050)

  • 21. Exploiting Chemical Protein Synthesis to Study the Role of Tyrosine Sulfation on Anticoagulants from Hematophagous Organisms.
    Maxwell JWC; Hawkins PME; Watson EE; Payne RJ
    Acc Chem Res; 2023 Oct; 56(19):2688-2699. PubMed ID: 37708351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effect of melagatran and lepirudin on clot-bound thrombin.
    Lebrazi J; Elalamy I; Samama MM
    Thromb Res; 2003 Jun; 110(4):249-52. PubMed ID: 14512090
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticoagulant therapy for percutaneous coronary intervention.
    Rao SV; Ohman EM
    Circ Cardiovasc Interv; 2010 Feb; 3(1):80-8. PubMed ID: 20160186
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recent developments in the biochemistry of hirudins].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):821-30. PubMed ID: 2483699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New anticoagulant protein from medicinal leech.
    Manuvera VA; Kharlampieva DD; Bobrovsky PA; Grafskaia EN; Brovina KA; Lazarev VN
    Biochem Biophys Res Commun; 2024 Feb; 696():149473. PubMed ID: 38241814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation on recombinant hirudin via oral route.
    Cen X; Ni J; Tan T; Liu X; Li C; Chen J; Huang Y; Zhu S; Bi Q
    Peptides; 2006 Apr; 27(4):836-40. PubMed ID: 16469415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers.
    Kautzleben M; Stein G; Sperschneider H; Nowak G
    Thromb Res; 2004; 113(3-4):187-95. PubMed ID: 15140582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human alpha- and zeta-thrombin inhibition by recombinant HV1 and HV2K47 hirudins.
    Witting JI; Brezniak DV; Hayes JR; Fenton JW
    Thromb Res; 1991 Aug; 63(4):473-9. PubMed ID: 1755001
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to the letter to the editor: anticoagulant activity of bivalirudin.
    Laine M; Paganelli F; Bonello L
    Expert Opin Pharmacother; 2019 Aug; 20(11):1415. PubMed ID: 31090465
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of heparin and Bivalirudin on the kinetics of clot formation: Viscoelastic coagulation testing.
    Hasija S; Kapoor PM
    Ann Card Anaesth; 2017; 20(1):122. PubMed ID: 28074815
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin.
    Wallén NH; Ladjevardi M; Albert J; Bröijersén A
    Thromb Res; 1997 Jul; 87(1):151-7. PubMed ID: 9253810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin.
    Molinaro RJ; Szlam F; Levy JH; Fantz CR; Tanaka KA
    Anesthesiology; 2008 Jul; 109(1):160-1. PubMed ID: 18580197
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolytic and anticoagulant effects of a recombinant staphylokinase-hirudin fusion protein.
    Ren K; Gong H; Huang J; Liu Y; Dong Q; He K; Tian L; Zhang F; Yu A; Wu C
    Thromb Res; 2021 Dec; 208():26-34. PubMed ID: 34688099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
    Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation.
    Fenyvesi T; Joerg I; Harenberg J
    Clin Chem; 2002 Oct; 48(10):1791-4. PubMed ID: 12324500
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical use of a new class of anticoagulant drugs: the direct thrombin inhibitors].
    Puccio D; Montalto S; Valerio MC; Ventimiglia A; Caronia A; Novo S
    G Ital Cardiol (Rome); 2006 Nov; 7(11):739-46. PubMed ID: 17216915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin-directed inhibitors: pharmacology and clinical use.
    White CM
    Am Heart J; 2005 Jan; 149(1 Suppl):S54-60. PubMed ID: 15644794
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced anticoagulant activity of hirudin-i analogue co-expressed with arylsulfotransferase in periplasm of E. coli BL21(DE3).
    Rai K; Chu X; Bao Z; Liang Y; Wang X; Yang J; Xian M; Sun Y; Nian R
    J Biotechnol; 2020 Nov; 323():107-112. PubMed ID: 32795502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery.
    Riess FC; Pötzsch B; Bader R; Bleese N; Greinacher A; Löwer C; Madlener K; Müller-Berghaus G
    Eur J Cardiothorac Surg; 1996; 10(5):386-8. PubMed ID: 8737698
    [No Abstract]   [Full Text] [Related]  

  • 40. A screening procedure to evaluate the anticoagulant activity and the kinetic behaviour of direct thrombin inhibitors.
    Rupin A; Mennecier P; de Nanteuil G; Laubie M; Verbeuren TJ
    Thromb Res; 1995 May; 78(3):217-25. PubMed ID: 7631302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.